Nr 566 Midterm Exam [Summer Practice] Question And Answers Latest 2023-2024 With Ngn

NR 566 MIDTERM EXAM [SUMMER PRACTICE] QUESTION AND ANSWERS LATEST 2023-2024 WITH NGN Which non-amphetamines are FDA approved for weight loss that have lower abuse risk? Phentermine and Diethylpropion How does Phentermine and Diethylpropion promote weight loss? -Promote weight loss by decreasing appetite -They are central nervous system (CNS) stimulants that suppress appetite by increasing the availability of norepinephrine at receptors in the brain What is the maximum recommended duration of use for non-amphetamines? 3 months or less What drug schedule are Phentermine and Diethylpropion under? Schedule IV What labs should be monitored with Phentermine and Diethylpropion? What condition should we screen for? -baseline CMP (watch electrolytes and creatinine) -screen for depression Phentermine adverse effects -increase HR and BP -dry mouth and constipation What is role of topiramate in weight loss? Increases satiety What are some Phentermine/topiramate contraindications for use? not approved in children and contraindicated with severe hepatic impairment How should we educate patient to take Phentermine/topiramate to avoid insomnia? given before 1600What are some high-risk patient conditions that we should use Phentermine/topiramate with caution? hx drug abuse, glaucoma, pregnant, HTN, hyperthyroidism Phentermine/topiramate adverse effects insomnia, nervousness, anxiety, depression, blurred vision Which of the following would be a contraindication